Treprostinil prodrug transdermal (Corsair Pharma/United Therapeutics Corporation)

曲前列尼尔前药透皮制剂 (Corsair Pharma/United Therapeutics Corporation)

Report date: 2025/04/10 13:18:52

Base Information

Drug NameTreprostinil prodrug transdermal (Corsair Pharma/United Therapeutics Corporation)

Drug Alias NameTransdermal treprostinil prodrug patchVPD-380TRX-248CO-254

ClassificationSmall molecules

Mechanisms of ActionProstanoid IP receptor agonists

TargetsProstanoid IP receptor

Therapy Area/IndicationsPulmonary Arterial Hypertension

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCorsair Pharma Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsPulmonary Arterial Hypertension

Inactive IndicationsN/A

ATC CodeN/A